Merck Doubles Down on Cancer and Vaccines with Strategic Equity Stake and New Collaborations
Merck & Co. is reinforcing its core therapeutic pillars through a strategic equity investment in Eikon Therapeutics and a global oncology partnership with Guardant Health, while also spearheading efforts to expand access to Ebola vaccines.